Dr. Julie Gralow on the Importance of Genetic Testing for Breast Cancer
Julie Gralow, MD, Professor, Medical Oncology Division, University of Washington School of Medicine, talks about the importance of women knowing which genetic tests they�ve previously had done for breast cancer.
Julie Gralow, MD, Professor, Medical Oncology Division, University of Washington School of Medicine, talks about the importance of women knowing which genetic tests they’ve previously had done for breast cancer. Of patients that have had standard genetic testing and then been referred back for multi-gene testing, 13% of them found a different mutation than they had initially aware of.
Gralow also touches on how genetic testing is increasingly helpful for catching breast cancer in women with a familial high risk of developing the disease.
Batalini Explores Role of UGT1A1 in Patients Treated With Sacituzumab Govitecan for HR+ MBC
April 22nd 2024During a Community Case Forum live event in partnership with The Arizona Clinical Oncology Society, Felipe Batalini, MD, discussed the TROPiCS-02 trial of sacituzumab govitecan and the impact of the UGT1A1 status on adverse event frequency.
Read More
